Last update 14 Nov 2024
Insulin degludec/Insulin aspart (Chongqing Chenan)
Last update 14 Nov 2024
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Insulin Degludec / Insulin Aspart Biosimilar (Chongqing Chenan Biopharmaceutical Co., Ltd.), 德谷门冬双胰岛素生物类似药（Chongqing Chenan Biopharmaceutical Co., Ltd.）, CA508 |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Insulin degludec/Insulin aspart (Chongqing Chenan)多中心、随机、开放、平行对照比较德谷门冬双胰岛素注射液（CA508注射液）和诺和佳®治疗2型糖尿病患者的有效性和安全性
[Translation] A multicenter, randomized, open, parallel controlled study to compare the efficacy and safety of degludec and insulin aspart injection (CA508 injection) and Tresiba® in the treatment of patients with type 2 diabetes
德谷门冬双胰岛素注射液在健康受试者中的随机、开放、单次给药、两周期、双交叉PK比对试验
[Translation] A randomized, open-label, single-dose, two-period, double-crossover PK comparison study of degludec and insulin aspart injection in healthy subjects
100 Clinical Results associated with Insulin degludec/Insulin aspart (Chongqing Chenan)
Login to view more data
100 Translational Medicine associated with Insulin degludec/Insulin aspart (Chongqing Chenan)
Login to view more data
100 Patents (Medical) associated with Insulin degludec/Insulin aspart (Chongqing Chenan)
Login to view more data
100 Deals associated with Insulin degludec/Insulin aspart (Chongqing Chenan)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | CN | 27 Aug 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free